E-LIB Suche - Ergebnisse für: Janet, Pierre

1

IKZF1plus is a frequent biomarker of adverse prognosis in M..:

Garcia-Solorio, Joaquin ; Núñez-Enriquez, Juan Carlos ; Jiménez-Olivares, Marco...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Treatment of retroperitoneal sarcoma results in improved ou..:

Walter, Kyla M. ; Culp, William T. N. ; Giuffrida, Michelle A....
Journal of the American Veterinary Medical Association. , 2024

Link: https://doi.org/10.2460/..

3

Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue in..:

Zhou, Xiao-Jian ; Good, Steven S ; Pietropaolo, Keith...
Expert Opinion on Investigational Drugs. 33 (2024) 1 - p. 9-17 , 2024

Link: https://doi.org/10.1080/..

4

Biomarkers and clinical outcomes after tezepelumab cessatio:

Brightling, Christopher E. ; Caminati, Marco ; Llanos, Jean-Pierre...
Annals of Allergy, Asthma & Immunology. , 2024

Link: https://doi.org/10.1016/..

5

Low-dose Paclitaxel with Pembrolizumab Enhances Clinical an..:

Bitting, Rhonda L. ; Tooze, Janet A. ; Goodman, Michael...
Cancer Research Communications. 4 (2024) 2 - p. 530-539 , 2024

Link: https://doi.org/10.1158/..

6

MultiRNAflow: integrated analysis of temporal RNA-seq data ..:

Loubaton, Rodolphe ; Champagnat, Nicolas ; Vallois, Pierre..
Bioinformatics. 40 (2024) 5 - p. , 2024

Link: https://doi.org/10.1093/..

7

ESE Emotionale und Soziale Entwicklung in der Pädagogik der..

ESE – Emotionale und Soziale Entwicklung in der Pädagogik der Erziehungshilfe und bei Verhaltensstörungen

Gingelmaier, Stephan ; Dietrich, Lars ; Langer, Janet... , 2024

Link: https://library.oapen.or..

8

Epidemiology of childhood acute leukemias in marginalized p..:

Flores-Lujano, Janet ; Allende-López, Aldo ; Duarte-Rodríguez, David Aldebarán...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

9

FIGURE 3 from Low-dose Paclitaxel with Pembrolizumab Enhanc..:

Rhonda L. Bitting ; Janet A. Tooze ; Michael Goodman...
https://figshare.com/articles/figure/FIGURE_3_from_Low-dose_Paclitaxel_with_Pembrolizumab_Enhances_Clinical_and_Immunologic_Responses_in_Platinum-refractory_Urothelial_Carcinoma/25288988. , 2024

Link: https://doi.org/10.1158/..

10

Diagnosis and management in Rubinstein-Taybi syndrome: firs..:

Lacombe, Didier ; Bloch-Zupan, Agnès ; Bredrup, Cecilie...
https://publications.aston.ac.uk/id/eprint/46181/1/Lacombe_RTSguidelines_final_version_clean_01-19-2024.pdf. , 2024

Link: https://publications.ast..

11

Supplementary table S1 from Low-dose Paclitaxel with Pembro..:

Rhonda L. Bitting ; Janet A. Tooze ; Michael Goodman...
doi:10.1158/2767-9764.25288982.v1. , 2024

Link: https://doi.org/10.1158/..

12

FIGURE 3 from Low-dose Paclitaxel with Pembrolizumab Enhanc..:

Rhonda L. Bitting ; Janet A. Tooze ; Michael Goodman...
doi:10.1158/2767-9764.25288988.v1. , 2024

Link: https://doi.org/10.1158/..

13

Diagnosis and management in Rubinstein-Taybi syndrome:first..:

Lacombe, Didier ; Bloch-Zupan, Agnès ; Bredrup, Cecilie...
https://pure.eur.nl/en/publications/f3eacd1f-32bd-49e5-8837-d72ddf9fb418. , 2024

Link: https://pure.eur.nl/en/p..

14

TABLE 1 from Low-dose Paclitaxel with Pembrolizumab Enhance..:

Rhonda L. Bitting ; Janet A. Tooze ; Michael Goodman...
https://figshare.com/articles/dataset/TABLE_1_from_Low-dose_Paclitaxel_with_Pembrolizumab_Enhances_Clinical_and_Immunologic_Responses_in_Platinum-refractory_Urothelial_Carcinoma/25288979. , 2024

Link: https://doi.org/10.1158/..

15

DataSheet_1_IKZF1plus is a frequent biomarker of adverse pr..:

Joaquin Garcia-Solorio ; Juan Carlos Núñez-Enriquez ; Marco Jiménez-Olivares...
doi:10.3389/fonc.2024.1337954.s001. , 2024

Link: https://doi.org/10.3389/..